We are live on !
Find out more
Daniel Devine & Co Portfolio holdings
AUM
$125M
Turnover
9.62%
1-Year Est. Return
14.12%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+14.12%
3 Year Est. Return
+34.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$122M
AUM Growth
-$18.6M
(-13%)
Cap. Flow
-$26.7M
Cap. Flow % of AUM
Cap. Flow %
-21.9%
Top 10 Holdings %
Top 10 Hldgs %
70.17%
Holding
49
New
2
Increased
–
Reduced
34
Closed
2
Avg Time Held
1.9
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$209K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.68M |
| 2 |
Boeing
BA
|
+$2.44M |
| 3 |
Apple
AAPL
|
+$1.32M |
| 4 |
Ashland
ASH
|
+$1.21M |
| 5 |
Johnson & Johnson
JNJ
|
+$1.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.01% |
| 2 | Healthcare | 12.86% |
| 3 | Financials | 6.83% |
| 4 | Technology | 6.73% |
| 5 | Industrials | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
State Street SPDR S&P 500 ETF Trust
SPY
$798B
| $29M | 23.77% |
122,805
-11,550
| -9% | -$2.68M |
2014 Q4
9 quarters
|
|
2
Invesco QQQ Trust
QQQ
$463B
| $15.3M | 12.59% |
115,880
-3,400
| -3% | -$434K |
2014 Q4
9 quarters
|
|
3
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.2B
| $14.6M | 12.01% |
46,815
| – | – |
2014 Q4
9 quarters
|
|
|
4
Apple
AAPL
$4.84T
| $7.19M | 5.9% |
200,252
-40,080
| -17% | -$1.32M |
2014 Q4
9 quarters
|
|
|
5
Johnson & Johnson
JNJ
$641B
| $4.82M | 3.96% |
38,732
-9,650
| -20% | -$1.15M |
2014 Q4
9 quarters
|
|
6
iShares Biotechnology ETF
IBB
$11.4B
| $3.92M | 3.22% |
40,095
-6,825
| -15% | -$653K |
2015 Q3
6 quarters
|
|
7
iShares MSCI Emerging Markets ETF
EEM
$28.3B
| $2.7M | 2.22% |
68,600
-10,000
| -13% | -$380K |
2014 Q4
9 quarters
|
|
8
GE Aerospace
GE
$333B
| $2.69M | 2.21% |
18,822
-7,198
| -28% | -$1.04M |
2014 Q4
9 quarters
|
|
9
Chevron
CVX
$440B
| $2.62M | 2.15% |
24,406
-6,957
| -22% | -$780K |
2014 Q4
9 quarters
|
|
10
Berkshire Hathaway Class B
BRK.B
$1.19T
| $2.62M | 2.15% |
15,700
| – | – |
2015 Q4
5 quarters
|
|
11
Pfizer
PFE
$171B
| $2.35M | 1.93% |
72,448
-8,346
| -10% | -$263K |
2014 Q4
9 quarters
|
|
12
AbbVie
ABBV
$505B
| $2.24M | 1.84% |
34,380
-11,750
| -25% | -$739K |
2014 Q4
9 quarters
|
|
13
Visa
V
$786B
| $1.91M | 1.57% |
21,480
-13,000
| -38% | -$1.12M |
2014 Q4
9 quarters
|
|
14
Walt Disney
DIS
$197B
| $1.76M | 1.45% |
15,552
-7,700
| -33% | -$848K |
2016 Q4
1 quarter
|
|
15
Novartis
NVS
$301B
| $1.76M | 1.44% |
26,393
-9,933
| -27% | -$662K |
2014 Q4
9 quarters
|
|
16
FedEx
FDX
$74.5B
| $1.73M | 1.42% |
8,860
-5,200
| -37% | -$993K |
2014 Q4
9 quarters
|
|
17
UnitedHealth
UNH
$363B
| $1.54M | 1.26% |
9,365
-5,700
| -38% | -$934K |
2015 Q3
6 quarters
|
|
|
18
Ashland
ASH
$3.34B
| $1.54M | 1.26% |
25,335
-20,890
| -45% | -$1.21M |
2014 Q4
9 quarters
|
|
19
Zoetis
ZTS
$34.3B
| $1.37M | 1.13% |
25,690
-19,454
| -43% | -$1.05M |
2014 Q4
9 quarters
|
|
|
RDS.B
20
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.37M | 1.12% |
24,500
| – | – |
2014 Q4
9 quarters
|
|
21
Blackrock
BLK
$180B
| $1.36M | 1.12% |
3,560
-2,100
| -37% | -$803K |
2014 Q4
9 quarters
|
|
22
Blackstone
BX
$94.3B
| $1.36M | 1.11% |
45,670
-80
| -0.2% | -$2.41K |
2014 Q4
9 quarters
|
|
23
Alphabet (Google) Class C
GOOG
$3.42T
| $1.36M | 1.11% |
31,980
-7,380
| -19% | -$303K |
2014 Q4
9 quarters
|
|
24
AstraZeneca
AZN
$285B
| $1.33M | 1.09% |
21,350
| – | – |
2015 Q1
8 quarters
|
|
25
DELISTED
Hanesbrands
HBI
| $1.25M | 1.03% |
60,395
-33,000
| -35% | -$700K |
2016 Q4
1 quarter
|
|
Similar funds
KFA
MGA
MAI
ACM
Daniel Devine & Co's Q1 2017 Portfolio in Review
As of Q1 2017, Daniel Devine & Co held 49 positions worth $122M, down 13% from $140M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Daniel Devine & Co withdrew a net $26.7M in Q1 2017, closing 2 positions and reducing 34 holdings. Its most notable exit was Boeing, an estimated $2.44M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 51% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Daniel Devine & Co opened a new position in Comcast worth $212K.
- Daniel Devine & Co's largest Q1 2017 buy was Comcast: 5,640 shares worth $212K.
- Daniel Devine & Co's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.68M.
- Daniel Devine & Co fully exited Boeing in Q1 2017, selling an estimated $2.44M.
- Daniel Devine & Co's ten largest holdings make up 70% of its $122M portfolio in Q1 2017.
- Daniel Devine & Co opened 2 new positions and closed 2 in Q1 2017.
- Daniel Devine & Co's portfolio value fell 13% quarter-over-quarter to $122M.
Based on Daniel Devine & Co's 13F filing for Q1 2017, filed 27 Apr 2017.